AU2021338957A1 - Compositions for preventing infection - Google Patents

Compositions for preventing infection Download PDF

Info

Publication number
AU2021338957A1
AU2021338957A1 AU2021338957A AU2021338957A AU2021338957A1 AU 2021338957 A1 AU2021338957 A1 AU 2021338957A1 AU 2021338957 A AU2021338957 A AU 2021338957A AU 2021338957 A AU2021338957 A AU 2021338957A AU 2021338957 A1 AU2021338957 A1 AU 2021338957A1
Authority
AU
Australia
Prior art keywords
composition
aqueous composition
weight
infection
clay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021338957A
Other languages
English (en)
Other versions
AU2021338957A9 (en
Inventor
Fabio Fais
Thomas Meyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Altamira Medica AG
Original Assignee
Altamira Medica AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altamira Medica AG filed Critical Altamira Medica AG
Publication of AU2021338957A1 publication Critical patent/AU2021338957A1/en
Publication of AU2021338957A9 publication Critical patent/AU2021338957A9/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2021338957A 2020-09-08 2021-09-03 Compositions for preventing infection Pending AU2021338957A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202063075590P 2020-09-08 2020-09-08
US63/075,590 2020-09-08
US202063119237P 2020-11-30 2020-11-30
US63/119,237 2020-11-30
US202163173816P 2021-04-12 2021-04-12
US63/173,816 2021-04-12
US202163230191P 2021-08-06 2021-08-06
US63/230,191 2021-08-06
PCT/EP2021/074417 WO2022053412A1 (en) 2020-09-08 2021-09-03 Compositions for preventing infection

Publications (2)

Publication Number Publication Date
AU2021338957A1 true AU2021338957A1 (en) 2023-05-25
AU2021338957A9 AU2021338957A9 (en) 2024-08-08

Family

ID=77864552

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021338957A Pending AU2021338957A1 (en) 2020-09-08 2021-09-03 Compositions for preventing infection

Country Status (7)

Country Link
US (2) US12280142B2 (https=)
EP (1) EP4210670A1 (https=)
JP (1) JP7821168B2 (https=)
AU (1) AU2021338957A1 (https=)
CA (1) CA3174314A1 (https=)
TW (1) TW202227104A (https=)
WO (1) WO2022053412A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202227104A (zh) 2020-09-08 2022-07-16 瑞士商艾爾塔米拉醫療有限公司 預防感染之組合物
US20260041706A1 (en) * 2022-08-04 2026-02-12 The Brigham And Women's Hospital, Inc. Mucus membrane formulations and uses thereof
WO2026010400A1 (ko) * 2024-07-03 2026-01-08 (주)시지바이오 스프레이형 점착성 점막 창상피복재

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC2204A1 (fr) 1989-10-31 1992-11-26 Columbia Lab Inc Composition et methode d'humidification de tissus
IT1275955B1 (it) 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
WO1996039031A1 (en) 1995-06-06 1996-12-12 Kimberly-Clark Worldwide, Inc. Microporous film containing a microbial adsorbent
US20020009478A1 (en) 1998-08-24 2002-01-24 Douglas Joseph Dobrozsi Oral liquid mucoadhesive compositions
US6183766B1 (en) 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
DE10064950A1 (de) 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
MXPA04011584A (es) * 2002-05-23 2005-03-31 Umd Inc Composiciones y metodo para la administracion y crioproteccion de drogas transmucosales.
EP1374856A1 (en) 2002-06-18 2004-01-02 Impetus AG Oily thixotropic nasal spray
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US20070031512A1 (en) 2005-08-03 2007-02-08 Amcol International Corporation Virus-interacting layered phyllosilicates and methods of inactivating viruses
US20070202055A1 (en) 2006-02-09 2007-08-30 Julianne Berry Pharmaceutical Formulations
KR101437708B1 (ko) 2006-12-05 2014-09-03 마리노메드 바이오테크놀로지 게엠베하 항바이러스 조성물과 이의 이용 방법
HRP20130402T1 (hr) 2007-08-24 2013-06-30 Marinomed Biotechnologie Gmbh Antivirusni pripravak koji sadrži sulfatirani polisaharid: jota-karagenan
WO2011029218A1 (zh) 2009-09-09 2011-03-17 济南康众医药科技开发有限公司 蒙脱石在制备药物中的应用
FR2954707B1 (fr) 2009-12-28 2016-01-08 Diffusion Tech Francaise Sarl Dispositif d'administration d'aerosol par voie buccale a visee rhinopharyngee, nasale ou nasosinusienne
WO2012067932A1 (en) 2010-11-19 2012-05-24 Milestone Scientific, Inc. A novel antimicrobial barrier and methods of use thereof to prevent sexually transmitted disease
US20140051732A1 (en) 2011-04-19 2014-02-20 Arm Pharmaceutical Llc Low-tack surface anti-microbial coating composition and method of application
WO2012145307A1 (en) 2011-04-19 2012-10-26 Brian Sokol Method of inhibiting harmful microorganisms and barrier-forming composition therefor
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
KR101474858B1 (ko) 2013-04-26 2014-12-19 리드메디 (주) 무방부제 약제를 위생적으로 보관하기 위한 필터부재를 갖는 비강 스프레이 장치
US10398465B2 (en) 2014-04-29 2019-09-03 Misonix Incorporated Ultrasonic surgical instrument assembly, related accessory, and associated surgical method
WO2015174910A1 (en) * 2014-05-13 2015-11-19 Aerosol Scandinavia Ab Composition having improved spraying characteristics comprising vegetable oils and triglycerides and/or mineral oils
ES2802530T3 (es) 2015-08-04 2021-01-20 Windstar Medical Gmbh Una composición nasal
TW202227104A (zh) 2020-09-08 2022-07-16 瑞士商艾爾塔米拉醫療有限公司 預防感染之組合物

Also Published As

Publication number Publication date
US12280142B2 (en) 2025-04-22
US20220071893A1 (en) 2022-03-10
US20260007596A1 (en) 2026-01-08
AU2021338957A9 (en) 2024-08-08
CA3174314A1 (en) 2022-03-17
WO2022053412A1 (en) 2022-03-17
TW202227104A (zh) 2022-07-16
JP2023539940A (ja) 2023-09-20
EP4210670A1 (en) 2023-07-19
JP7821168B2 (ja) 2026-02-26

Similar Documents

Publication Publication Date Title
US20260007596A1 (en) Compositions for preventing infection
AU2012204557B2 (en) Bepotastine compositions
US20090191288A1 (en) Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases
ES2834985T3 (es) Composición que contiene cineol para administración nasal
JP5604395B2 (ja) マイクロエマルジョンおよび気道疾患を防ぐためのその使用
KR20060118573A (ko) 항바이러스성 약제학적 조성물
ES2171590T7 (es) Preparación farmacéutica para el tratamiento de rinitis agudas que contiene un simpaticomimético y pantotenol y/o ácido pantoténico
US9662360B2 (en) Treatment of herpes, pseudomonas, staph, and hepatitis
US9023815B2 (en) Method for treating rhinitis and sinusitis by rhamnolipids
JP2017522330A (ja) ポビドンヨードを使用した感冒の治療および予防
CN106659734A (zh) 用于经鼻施用的含硅油制剂
CN107847433A (zh) 鼻用组合物
ES2860098T3 (es) Composición para la aplicación nasal
WO2021202332A1 (en) Aqueous formulations containing povidone iodine for effective treatment and prevention of virus infections
CN117083057A (zh) 用于预防感染的组合物
US20230218557A1 (en) A fatty acid based composition for treatment and/or prevention of enveloped-virus related infections
JP2012193159A (ja) 鼻用スプレー
US20240165191A1 (en) Compositions and methods for reducing the transmissivity of illnesses using an oral delivery system
US20100069315A1 (en) Method and medicament for treating ocular infections
JP7391026B2 (ja) モメタゾン及びオロパタジンの組み合わせを用いた小児対象におけるアレルギー性鼻炎の治療
Mohammad et al. Development and Physicochemical Characterization of a Poly-Herbal Hydrosol-Based Intranasal Spray for the Management of Rhinosinusitis
US20210330587A1 (en) Oral sanitizer and immune support for viral and bacterial prevention
MX2014003546A (es) Composicion farmaceutica de dosis fija que comprende mometasona y azelastina.

Legal Events

Date Code Title Description
SREP Specification republished